全文获取类型
收费全文 | 31944篇 |
免费 | 2799篇 |
国内免费 | 1463篇 |
专业分类
耳鼻咽喉 | 102篇 |
儿科学 | 334篇 |
妇产科学 | 147篇 |
基础医学 | 2532篇 |
口腔科学 | 600篇 |
临床医学 | 2811篇 |
内科学 | 5947篇 |
皮肤病学 | 213篇 |
神经病学 | 1788篇 |
特种医学 | 1177篇 |
外国民族医学 | 45篇 |
外科学 | 4024篇 |
综合类 | 6031篇 |
现状与发展 | 2篇 |
预防医学 | 1020篇 |
眼科学 | 147篇 |
药学 | 2237篇 |
30篇 | |
中国医学 | 1431篇 |
肿瘤学 | 5588篇 |
出版年
2024年 | 88篇 |
2023年 | 531篇 |
2022年 | 1006篇 |
2021年 | 1339篇 |
2020年 | 1193篇 |
2019年 | 986篇 |
2018年 | 895篇 |
2017年 | 1085篇 |
2016年 | 1227篇 |
2015年 | 1228篇 |
2014年 | 1919篇 |
2013年 | 2062篇 |
2012年 | 1741篇 |
2011年 | 1838篇 |
2010年 | 1462篇 |
2009年 | 1435篇 |
2008年 | 1536篇 |
2007年 | 1769篇 |
2006年 | 1432篇 |
2005年 | 1343篇 |
2004年 | 1083篇 |
2003年 | 910篇 |
2002年 | 878篇 |
2001年 | 865篇 |
2000年 | 763篇 |
1999年 | 612篇 |
1998年 | 552篇 |
1997年 | 502篇 |
1996年 | 475篇 |
1995年 | 468篇 |
1994年 | 436篇 |
1993年 | 330篇 |
1992年 | 292篇 |
1991年 | 269篇 |
1990年 | 237篇 |
1989年 | 201篇 |
1988年 | 196篇 |
1987年 | 147篇 |
1986年 | 117篇 |
1985年 | 149篇 |
1984年 | 119篇 |
1983年 | 73篇 |
1982年 | 79篇 |
1981年 | 73篇 |
1980年 | 66篇 |
1979年 | 41篇 |
1978年 | 30篇 |
1977年 | 29篇 |
1976年 | 28篇 |
1975年 | 24篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
Neil B. Marya Patrick D. Powers Larissa Fujii-Lau Barham K. Abu Dayyeh Ferga C. Gleeson Shigao Chen Zaiyang Long David M. Hough Vinay Chandrasekhara Prasad G. Iyer Elizabeth Rajan William Sanchez Tarek Sawas Andrew C. Storm Kenneth K. Wang Michael J. Levy 《Gastrointestinal endoscopy》2021,93(5):1121-1130.e1
- Download : Download high-res image (151KB)
- Download : Download full-size image
992.
993.
994.
995.
《Brain & development》2020,42(4):369-372
We present the case of an 8-month-old boy with the repeated recurrence of vesicles from the time of birth and who subsequently manifested psychomotor developmental delay. We retrospectively diagnosed the patient with congenital herpes simplex virus (HSV) infection. Computed tomography showed multiple calcifications in the periventricular white matter and thalami. The bilateral deep white matter showed an abnormally high signal intensity on T2-weighted magnetic resonance imaging. The patient required consecutive, suppressive therapy with valacyclovir to prevent the repeated recurrence of vesicles. This case presented a milder phenotype of congenital HSV infection in comparison to previous reports, and highlights the importance of the careful examination for this disease when neonates present with skin lesions. 相似文献
996.
BackgroundMultidisciplinary management of patients with locally advanced gastric cancer (LAGC) remains unstandardized worldwide. We performed a systemic review to summarize the advancements, regional differences, and current recommended multidisciplinary treatment strategies for LAGC.MethodsEligible studies were identified through a comprehensive search of PubMed, Web of Science, Cochrane Library databases and Embase. Phase 3 randomized controlled trials which investigated survival of patients with LAGC who underwent gastrectomy with pre-/perioperative, postoperative chemotherapy, or chemoradiotherapy were included.ResultsIn total, we identified 11 studies of pre-/perioperative chemotherapy, 38 of postoperative chemotherapy, and 14 of chemoradiotherapy. In Europe and the USA, the current standard of care is perioperative chemotherapy for patients with LAGC using the regimen of 5-FU, folinic acid, oxaliplatin and docetaxel (FLOT). In Eastern Asia, upfront gastrectomy and postoperative chemotherapy is commonly used. The S-1 monotherapy or a regimen of capecitabine and oxaliplatin (CapOx) are used for patients with stage II disease, and the CapOx regimen or the S-1 plus docetaxel regimen are recommended for those with stage III Gastric cancer (GC). The addition of postoperative radiotherapy to peri- or postoperative chemotherapy is currently not recommended. Additionally, clinical trials testing targeted therapy and immunotherapy are increasingly performed worldwide.ConclusionsRecent clinical trials showed a survival benefit of peri-over postoperative chemotherapy and chemoradiotherapy. As such, this strategy may have a potential as a global standard for patients with LAGC. Outcome of the ongoing clinical trials is expected to establish the global standard of multidisciplinary treatment strategy in patients with LAGC. 相似文献
997.
Hao-Min Cheng Ling-Jan Chiou Tzu-Ching Chen Shih-Hsien Sung Chen-Huan Chen Hui-Chu Lang 《Health policy (Amsterdam, Netherlands)》2019,123(2):229-234
Objective
To evaluate the cost-effectiveness of using drugeluting stents (DES) compared to bare-metal stents (BMS) for coronary heart disease (CHD).Data sources/study setting
Data were obtained from the National Health Insurance Longitudinal Health Insurance Database, which contains claims data for 1,000,000 beneficiaries. The data were randomly sampled from all beneficiaries.Study design
A retrospective claims data analysis.Data collection/extraction methods
Patients with stable coronary heart disease who underwent coronary stent implantation from 2007 to 2008 were recruited and followed to the end of 2013. After a 2:1 propensity score matched by gender, age, stent number, and the Charlson comorbidity index (CCI), 852 patients with 568 stents in the BMS group and 284 stents in the DES group were included. The cumulative medical costs for both matched groups were estimated with the Kaplan-Meier Sample Average (KMSA), and then the incremental cost-effectiveness ratio (ICER) was estimated.Principal findings
The ICER of DES vs. BMS was NT$ 663,000 per cardiovascular death averted and NT$ 238,394 per cardiovascular death or coronary event averted in five years from the insurer perspective.Conclusion
Percutaneous coronary intervention (PCI) with DES was a more cost-effective strategy than PCI with BMS for CHD patients during the five-year follow-up. 相似文献998.
Nikolaos Charalampakis Elena Elimova Yusuke Shimodaira Hironori Shiozaki Roopma Wadhwa Jaffer A Ajani 《Expert opinion on pharmacotherapy》2015,16(7):955-960
Gastric cancer (GC) continues to be a significant problem worldwide and is the third leading cause of cancer death. Armamentarium to treat GC whether it is potentially curable or metastatic (incurable) has changed little over the last decades with only two new agents being approved (trastuzumab and ramucirumab). Many relatively healthy patients after second-line therapy have limited and generally ineffective options. The recent The Cancer Genome Atlas analysis has uncovered four genotypes of GC; however, it is not sufficient to change our treatment strategies and more work needs to be done. The popular front-line regimen containing a platinum compound and a fluoropyrimidine is widely used for drug development and has worked well globally. Thus, this combination appears suitable for adding a biologic agent. The search for new classes of cytotoxics has almost stopped, but it is clear that cytotoxic therapy continues to contribute and it is here to stay. Biologic agents that modulate the immune system of the host appear promising along with many other biologics that can potentially inhibit signaling pathways that are often employed by GC cells. We will briefly describe the efforts that have targeted EGFR, mTOR, angiogenesis and MET pathways. 相似文献
999.
《Archivos de bronconeumologia》2014,50(11):484-489
This article analyzes the concept of inactive fibrotic lesions of presumed tuberculous origin (old healed tuberculosis), defined by radiological characteristics and a positive tuberculin skin test (TST), and we examine the evidence-based foundation for the indication of treatment of latent tuberculosis infection in these cases. We explore the risk of reactivation in older and recent literature, and the problems raised by the differential diagnosis with active tuberculosis with negative bacteriology. We also analyze data on the prevalence of fibrotic lesions in the recent literature. We examine the possible role of Interferon Gamma Release Assays (IGRAs) versus TST and other molecular antigen detection techniques in sputum that can aid in establishing the diagnosis and we discuss the current indications for chemoprophylaxis and the different options available. We propose diagnostic guidelines and therapeutic algorithms based on risk stratification by age and other factors in the management of radiological lesions that raise a differential diagnosis between fibrotic lesions and active pulmonary tuberculosis with negative bacteriology. 相似文献
1000.
�� �� 《中国实用外科杂志》2019,39(3):231-236
日本《胃癌治疗指南》(以下简称指南)目前已成为胃癌临床治疗的重要指导性文件,其每次更新均成为全球胃癌领域的重大事件,备受瞩目。2018年第5版指南发行,2019年2月在日本静冈召开的“第91届日本胃癌学会年会”再度对相关内容进行了严谨而深刻的讨论,提出了新的修改意见。随着新的循证医学证据的出现,指南也在不断更新,胃癌的治疗方式也不断与时俱进。 相似文献